JIBI INKOKA TEMBO

Mucoceles of the posterior ethmoid and sphenoid sinus can cause dysfunctions of various organs, including visual disturbances, interference with eye movements, interference with vision, meningitis, etc. We encountered a comparatively rare case of Onodi cell mucocele manifesting as bilateral visual disturbances omit.
Resolution of the visual disturbance was obtained by early treatment, that is endoscopic sinus surgery (ESS). These findings suggest that early ESS may be of benefit in patients with sinus mucoceles associated with various dysfunctions.

View full abstract

We report a case of transoral removal of extrapharyngeal foreign body with a WEERDA-type videolaryngoscope. A 65-year-old female patient presented with the complaints of a sore throat after eating a yellowtail. CT revealed a fish bone in the extrapharyngeal space. The fish bone was removed using a WEERDA-type videolaryngoscope. Use of the videolaryngoscope is superior to that of a traditional laryngoscope in terms of improved visualization of the pharynx and larynx. Furthermore, more space is available for the operator to use surgical instruments than that available with the use of a traditional laryngoscope. Use of a WEERDA-type videolaryngoscope for transoral removal of extarapharyngeal foreign body offers advantages to the operator, including improved optimal view and availability of more space for the operator which allows better control of the instruments.

View full abstract

Show abstractHide abstract

The number of patients with Japanese cedar pollinosis is increasing yearly, therefore prophylactic therapy is recommended. A survey carried out to measure the satisfaction of the patients with their prophylactic treatment revealed a high percentage of patients who were satisfied with the treatment. On the other hand, many patients indicated dissatisfaction with the treatment efficacy, which can vary based on the severity of the cedar pollen dispersal in each season, and the cost. In addition, there are no established criteria for determining the proper drug dose of olopatadine hydrochloride for prophylaxis. Therefore, we evaluated the clinical prophylactic efficacy of half-dose olopatadine hydrochloride.
The subjects were divided into 3 groups: 1) patients who took prophylactic treatment with half the usual dose of olopatadine hydrochloride before the beginning of the pollen season, 2) patients who took the usual dose of olopatadine hydrochloride before the beginning of the pollen season, and 3) patients who received intra-season administration of olopatadine hydrochloride without prophylactic treatment. We used symptom diaries and the Japan rhinoconjunctivitis quality of life questionnaire (JRQLQ) to determine the subjective symptom, objective nasal finding and QOL scores.
The nasal and eye symptom scores of all groups were low in the pollen season, possibly due to the mild cedar pollen season. Midway through the pollen season, only the severity of nasal discharge showed significant improvement in the usual-dose prophylaxis group as compared with that in the intra-season treatment group. Also, the total scores on the JRQLQ showed improvement from early in the pollen season only in the half-dose group as compared with that in the intra-season treatment group. There were no significant differences in the nasal symptom, eye symptom or QOL scores during the pollen season between the half-dose and normal-dose groups.
These findings suggest that half-dose olopatadine hydrochloride is useful for prophylaxis against Japanese cedar pollinosis.

View full abstract

Download PDF (1232K)

We investigated the efficacy of dexamethasone cipecilate nasal spray in the early treatment of seasonal allergic rhinitis (Japanese cedar pollinosis). Dexamethasone cipecilate 400 μg delivered with a specific intranasal spraying device was administered once daily to allergic rhinitis patients visiting the hospital just prior to the cedar pollen season (early treatment group) or after cedar pollen dispersal (late treatment group), and the nasal symptoms and QOL score were compared between the early treatment group with late early treatment group. The nasal symptom score and QOL score at the peak of pollen dispersal were lower in the early treatment group than those in the late treatment group, and we found that the nasal symptoms of the early treatment group were suppressed by dexamethasone cipecilate nasal spray. These results suggest that early treatment with dexamethasone cipecilate nasal spray is effective for reducing the nasal symptoms of seasonal allergic rhinitis.

View full abstract

Register with J-STAGE for free!